HIV Type 2 in New York City, 2000–2008 | Zendy

Lucia V. Torian | Zendy; Joanna Eavey | Zendy; Amado Punsalang | Zendy; Robert E. Pirillo | Zendy; Lisa A. Forgione | Zendy; Scott A. Kent | Zendy; William R. Oleszko | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HIV Type 2 in New York City, 2000–2008

Author(s) -

Lucia V. Torian,

Joanna Eavey,

Amado Punsalang,

Robert E. Pirillo,

Lisa A. Forgione,

Scott A. Kent,

William R. Oleszko

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/657117

Subject(s) - medicine , immunosuppression , human immunodeficiency virus (hiv) , immunology , virology , serology , viral load , antibody

Antibody cross-reactivity complicates differential diagnosis of human immunodeficiency virus (HIV) type 2 (HIV-2) using standard serologic screening and confirmatory tests for HIV. HIV type 1 (HIV-1) viral load testing does not detect HIV-2. Although HIV-2 is, in general, less pathogenic than HIV-1, it can lead to immunosuppression and clinical AIDS, and there are important differences in the selection of antiretroviral therapy for HIV-2-related immunosuppression that make it imperative to differentiate between the 2 viruses. The New York City Department of Health (New York, NY) seeks to facilitate accurate diagnosis and surveillance of HIV-2 infection in the city.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research